the new list relied on data from 2017 to 2022, which means a natural time lag, the team said. it’s urging updates every three to five years, not once a decade.
microbes can evolve rapidly, within hours. however, unlike the heydays of the 80s, “it’s now a completely different kettle of fish,” wright said. “there are very few drug companies working in the field.”
“they can’t make money on it,” he said. “antibiotics cure disease. if you’re a large pharma company, you like to be controlling chronic diseases, because then people take your drugs for a very long time,” meaning a guaranteed revenue stream, he said.
in work published recently in the journal nature, wright’s lab isolated a protein from a bacterium taken from a soil sample collected from his technician’s backyard in hamilton. in lab mice, “it has activity against almost all of the pathogens that we care about on that list.” he’s now trying to develop it into a drug candidate.
that’s going to take time, and a lot of money. “and no matter what drug you bring into the country, resistance is inevitable,” amaratunga said.
both she and wright emphasized the need for prevention, including judicious and appropriate use of antibiotics, beefed up surveillance, early detection and vaccines.